1. Home
  2. AEHR vs VNDA Comparison

AEHR vs VNDA Comparison

Compare AEHR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEHR
  • VNDA
  • Stock Information
  • Founded
  • AEHR 1977
  • VNDA N/A
  • Country
  • AEHR United States
  • VNDA United States
  • Employees
  • AEHR N/A
  • VNDA N/A
  • Industry
  • AEHR Electrical Products
  • VNDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEHR Industrials
  • VNDA Health Care
  • Exchange
  • AEHR Nasdaq
  • VNDA Nasdaq
  • Market Cap
  • AEHR 308.5M
  • VNDA 303.2M
  • IPO Year
  • AEHR 1997
  • VNDA 2006
  • Fundamental
  • Price
  • AEHR $15.75
  • VNDA $5.92
  • Analyst Decision
  • AEHR Hold
  • VNDA Buy
  • Analyst Count
  • AEHR 2
  • VNDA 1
  • Target Price
  • AEHR $12.00
  • VNDA $11.00
  • AVG Volume (30 Days)
  • AEHR 1.3M
  • VNDA 1.1M
  • Earning Date
  • AEHR 07-16-2024
  • VNDA 07-25-2024
  • Dividend Yield
  • AEHR N/A
  • VNDA N/A
  • EPS Growth
  • AEHR 4.00
  • VNDA N/A
  • EPS
  • AEHR 0.52
  • VNDA N/A
  • Revenue
  • AEHR $71,887,000.00
  • VNDA $177,604,000.00
  • Revenue This Year
  • AEHR $2.23
  • VNDA $2.98
  • Revenue Next Year
  • AEHR $4.23
  • VNDA $19.49
  • P/E Ratio
  • AEHR $29.26
  • VNDA N/A
  • Revenue Growth
  • AEHR 14.14
  • VNDA N/A
  • 52 Week Low
  • AEHR $9.83
  • VNDA $3.30
  • 52 Week High
  • AEHR $54.10
  • VNDA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • AEHR 70.71
  • VNDA 56.76
  • Support Level
  • AEHR $10.55
  • VNDA $5.13
  • Resistance Level
  • AEHR $16.43
  • VNDA $5.39
  • Average True Range (ATR)
  • AEHR 0.93
  • VNDA 0.26
  • MACD
  • AEHR 0.53
  • VNDA -0.03
  • Stochastic Oscillator
  • AEHR 89.70
  • VNDA 70.54

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for the company's products in package, wafer level, and singulated die/module level test. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

Share on Social Networks: